Lippi (2020)
Hypertension and its severity or mortality in Coronavirus Disease 2019 (COVID-19): a pooled analysis
https://doi.org/10.20452/pamw.15272
https://www.ncbi.nlm.nih.gov/pubmed/32231171
Comorbidities
Hypertension (Present vs. Not present)
COVID-19 (death)
Odds ratio: 2.420 (1.510-3.900) Univariate analysis

China

Meta-analysis

Published studies

290

All studies reporting data on prevalence of hypertension in adult (i.e., aged 18 years or older) laboratory-confirmed COVID-19 patients, with or without severe disease, or COVID-19 non-survivors and survivors

Aggregate data not stated

Not applicable

0


COVID-19 (death)

0

Not stated


Comorbidities

Hypertension

Not present

Present


Odds ratio

2.420 (1.510-3.900)

No

Yes

No

Not applicable


Size of study population based on 2 studies included in the analysis (Figure 2) Number of cases (i.e. deaths) not stated Number of cases and total number of patients for reference/comparison groups not stated

Average